• Forum Login or
  • Register
Results 1 to 2 of 2
  1. #1 29th October 2015 
    briannagodess's Avatar
    Join Date
    Sep 2015
    Posts
    54
    Thanks
    1
    Thanked 2 Times in 2 Posts

    Melanocortin Receptor's Role in Intestinal Dysfunction

    Introduction

    Intra-abdominal hypertension is a life-threatening disease. Melanocortin-4 (MC4) receptor activation exhibits life-saving properties. The aim of the present study was to examine whether treatment with the MC4 receptor agonist RO27-3225 helps in intestinal injury in IAH rats.

    Methods

    A total of 72 male Sprague–Dawley rats were randomized into six groups. Group 1 was the sham group. Group 2, the sham + RO group, received RO27-3225 (180 μg/kg, intraperitoneally). IAH was induced in group 3, the IAH group, by blood draw (mean arterial pressure = 30 mm Hg for 90 min) followed by shed blood and/or Ringer solution reinfusion. Intra-abdominal pressure was increased to 20 mm Hg by injecting air into the peritoneal cavity. Group 4, the RO group, was administered RO27-3225 at 5 min after blood draw. Groups 5 and 6 were the chlorisondamine (Chl) and HS024 groups, in which the rats were pretreated with the nicotinic acetylcholine receptor antagonist Chl or selective MC4 receptor antagonist (HS024), respectively, at 2 min before RO27-3225 was administered.

    Results

    RO27-3225 restored mean arterial pressure, reduced tumor necrosis factor-α, and interleukin-1β messenger RNA expression increased by IAH, alleviated histologic damage, and improved superoxide dismutase activity in the intestine. Compared with the IAH group, the levels of intestinal fatty acid-binding protein, intestinal edema and intestinal permeability were lower in the RO group. Furthermore, the RO27-3225 treatment increased the expression of Rho-associated coiled–coil-containing protein kinase 1 and phosphorylated myosin light chain. Chl and HS024 abrogated the protective effects of RO27-3225.

    Conclusions

    These data indicate that the MC4 receptor agonist counteracts the intestinal inflammatory response, ameliorating intestinal injury in experimental secondary IAH by MC4 receptor-triggered activation of the cholinergic anti-inflammatory pathway. It may represent a promising strategy for the treatment of IAH in the future.

    Source:

    http://www.journalofsurgicalresearch...047-5/abstract

    This is such great research on the role of melanocortin in IAH. This could potentially help people and save lives. I hope more researchers study on this matter and prove the role of melanocortin on this disease.
  2. #2 24th January 2016 
    mysterio's Avatar
    Join Date
    Jan 2016
    Posts
    29
    Thanks
    0
    Thanked 0 Times in 0 Posts
    Well, well, well, this is quite a complicated one. I mean I am a user of mt-2 and peps, but this kind of info is too complex for me to immediately absorb the idea. Lol. Anyway, thanks for posting something like this in this forum.

Similar Threads

  1. The Role of Race and Melanocortin Receptor in Post Burn HTS
    By briannagodess in forum Peptides Forum
    Replies: 1
    Last Post: 24th January 2016, 04:25 AM
  2. Melanocortin-1 Receptor Genotype
    By Semin in forum Peptides Forum
    Replies: 1
    Last Post: 20th July 2011, 12:02 AM
  3. Melanocortin protein receptor
    By Semin in forum Melanotan Forum
    Replies: 2
    Last Post: 16th August 2010, 06:10 PM
  4. Melanocortin Receptor System
    By Semin in forum Melanotan Forum
    Replies: 0
    Last Post: 6th August 2010, 12:17 AM